임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 4상모집 중단 (진행 중)· HIVImplementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
협력: 길리어드
- 1상모집 중단 (진행 중)· HIV-1-infectionStudy of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV
리드: 길리어드
- 단계 미표기모집 중단 (진행 중)· Liver CirrhosisLiver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
협력: 길리어드
- 3상모집 중단 (진행 중)· HIV Pre-exposure ProphylaxisStudy of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
리드: 길리어드
- 4상모집 중단 (진행 중)· Ulcerative ColitisA Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice
협력: 길리어드
- 2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaStudy of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01
리드: 길리어드
- 1/2상모집 중단 (진행 중)· Advanced Breast CancerClinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer
협력: 길리어드
- 2/3상모집 중단 (진행 중)· HIV-1-infectionStudy of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
리드: 길리어드
- 3상모집 중단 (진행 중)· HIV-1-infectionStudy to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
리드: 길리어드 · 협력: 머크(MSD)
- 3상모집 중단 (진행 중)· HIV-1-InfectionStudy to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
리드: 길리어드 · 협력: 머크(MSD)
- 2상모집 중단 (진행 중)· Pre-Exposure Prophylaxis of HIV InfectionStudy of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)
리드: 길리어드
- 1상모집 중단 (진행 중)· Lymphomas Non-Hodgkin's B-CellA Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous Treatment
협력: 길리어드
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
협력: 길리어드
- 해당없음모집 중단 (진행 중)· HIV/AIDSCommunity-based, Peer-delivered PrEP for Female Sex Workers in Rural Uganda: The Peers for PrEP (P4P) Study
협력: 길리어드
- 2상모집 중단 (진행 중)· Ulcerative ColitisStudy of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 길리어드
- 3상모집 중단 (진행 중)· HIV-1-infectionStudy to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
리드: 길리어드
- 2상모집 중단 (진행 중)· Relapsed/Refractory Mantle Cell LymphomaStudy of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
협력: 길리어드
- 2상모집 중단 (진행 중)· Biliary Tract CarcinomaStudy of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
협력: 길리어드
- 2상모집 중단 (진행 중)· Ovarian CarcinomaA Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
협력: 길리어드
- 2상모집 중단 (진행 중)· Pre-Exposure Prophylaxis of HIV InfectionStudy of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
리드: 길리어드
- 2상모집 중단 (진행 중)· Her 2 Positive Breast CancerA Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
협력: 길리어드
- 2상모집 중단 (진행 중)· Pre-Exposure Prophylaxis of HIV InfectionStudy of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
리드: 길리어드
- 1상모집 중단 (진행 중)· Relapsed/Refractory Large B-cell LymphomaStudy of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
협력: 길리어드
- 1상모집 중단 (진행 중)· Solid TumorsStudy of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
리드: 길리어드
- 단계 미표기모집 중단 (진행 중)· HIVHIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil
협력: 길리어드
- 3상모집 중단 (진행 중)· Locally Advanced or Unresectable Metastatic Breast CancerStudy of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy
리드: 길리어드
- 2상모집 중단 (진행 중)· Lung CancerStudy of Novel Treatment Combinations in Patients With Lung Cancer
리드: 길리어드
- 2상모집 중단 (진행 중)· Advanced Non-Small Cell Lung CancerStudy With Various Immunotherapy Treatments in Participants With Lung Cancer
리드: 길리어드
- 3상모집 중단 (진행 중)· High-risk Large B-cell Lymphoma (LBCL)Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
협력: 길리어드
- 단계 미표기모집 중단 (진행 중)· Chronic Hepatitis D InfectionStudy of Bulevirtide in Participants With Chronic Hepatitis D Infection
리드: 길리어드
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungStudy of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)
리드: 머크(MSD) · 협력: 길리어드
- 3상모집 중단 (진행 중)· Advanced Upper Gastrointestinal Tract AdenocarcinomaA Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
협력: 길리어드
- 3상모집 중단 (진행 중)· Non-small Cell Lung CancerZimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
리드: 길리어드
- 3상모집 중단 (진행 중)· Relapsed/Refractory Follicular LymphomaStudy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
협력: 길리어드
- 2상모집 중단 (진행 중)· Locally Advanced or Metastatic Urothelial CarcinomaA Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
협력: 길리어드
- 2/3상모집 중단 (진행 중)· HIV-1-infectionStudy to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
리드: 길리어드
- 3상모집 중단 (진행 중)· Triple Negative Breast CancerStudy of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
리드: 길리어드 · 협력: 머크(MSD)
- 3상모집 중단 (진행 중)· Triple Negative Breast CancerStudy of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
리드: 길리어드
- 2상모집 중단 (진행 중)· Multiple MyelomaStudy of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
협력: 길리어드
- 2상모집 중단 (진행 중)· Gastrointestinal Tract MalignanciesA Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
협력: 길리어드
- 2상모집 중단 (진행 중)· Non-small Cell Lung CancerStudy of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
리드: 길리어드 · 협력: 머크(MSD)
- 4상모집 중단 (진행 중)· Hepatitis C, ChronicSofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
협력: 길리어드
- 1상모집 중단 (진행 중)· Breast CancerAlpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
협력: 길리어드, 노바티스
- 3상모집 중단 (진행 중)· Non-Small Cell Lung CancerStudy of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
리드: 길리어드
- 1/2상모집 중단 (진행 중)· Advanced Solid TumorStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
리드: 길리어드
- 2상모집 중단 (진행 중)· HIV-1 InfectionStudy Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV
리드: 길리어드 · 협력: 머크(MSD)
- 3상모집 중단 (진행 중)· Pre-Exposure Prophylaxis of HIV InfectionPre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection
리드: 길리어드
- 단계 미표기모집 중단 (진행 중)· COVID-19CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
협력: 길리어드
- 3상모집 중단 (진행 중)· Pre-Exposure Prophylaxis of HIV InfectionStudy of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
리드: 길리어드
- 2상모집 중단 (진행 중)· Anatomic Stage IV Breast Cancer AJCC v8Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
협력: 길리어드
- 1/2상모집 중단 (진행 중)· Metastatic Urothelial CarcinomaCombination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients
협력: BMS, 길리어드
- 2상모집 중단 (진행 중)· Non Small Cell Lung CancerStudy Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
협력: 길리어드
- 3상모집 중단 (진행 중)· Metastatic Breast CancerAsian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)
리드: 길리어드
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.